Immunome Inc.IMNMEarnings & Financial Report
Nasdaq
NextMar 19, 2026
IMNM Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-60.1M
Net Profit
$-57.5M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.65
Immunome Inc. Q3 2025 Financial Summary
Immunome Inc. reported revenue of $0 for Q3 2025, with a net profit of $-57.5M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-57.5M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Immunome Inc. Annual Revenue by Year
Immunome Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $9.0M).
| Year | Annual Revenue |
|---|---|
| 2024 | $9.0M |
| 2023 | $14.0M |
| 2022 | $5.0K |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $1.0M | $2.4M | $2.9M | $2.7M | $2.9M | $4.0M | $0 |
| YoY Growth | 382500.0% | -56.5% | -44.5% | -18.4% | -28.4% | 184.4% | 69.8% | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $148.5M | $319.8M | $296.2M | $256.9M | $240.2M | $342.7M | $296.3M | $299.4M |
| Liabilities | $28.7M | $34.2M | $42.4M | $42.0M | $59.1M | $35.6M | $27.0M | $35.5M |
| Equity | $119.9M | $285.6M | $253.8M | $214.9M | $181.2M | $307.1M | $269.3M | $263.9M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-17.5M | $-11.2M | $-23.4M | $-34.2M | $-42.1M | $-53.1M | $-49.4M | $-40.5M |